views
The aesthetic injectables market is growing rapidly owing to the high demand for non-surgical aesthetic procedures across the world. Aesthetic injectables refer to wrinkle treating injections, dermal fillers, and other products that are injected under the skin to smoothen wrinkles, relax frown lines, and for lip augmentation and other procedures. With growing preference for looking youthful and aesthetic consciousness among people, the demand for these non-surgical procedures is high. Aesthetic injectables help relax muscles and reducre or fill lines and wrinkles to restore a smoother, more youthful look. They provide visible results with less pain and shorter recovery time compared to surgical procedures.
The global aesthetic injectables market size is estimated to be valued at US$ 19.76 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period of 2024 to 2031.
Key Takeaways
Key players operating in the aesthetic injectables market are AbbVie, Galderma, Merz Pharma, Teoxane Laboratories, Sinclair Pharma, Suneva Medical, Croma-Pharma GmbH, Luminera Derm, Johnson & Johnson, Revance Therapeutics, Hyaltech Ltd, Bioxis Pharmaceuticals, Prollenium Medical Technologies, SciVision Biotech Inc., and Bloomage BioTechnology Corporation Ltd.
Key opportunities in the market include rising medical tourism in emerging markets for Aesthetic Injectables Market Size procedures and increasing marketing and awareness about non-invasive aesthetic treatments. With growing aesthetic consciousness, the demand for aesthetic procedures is rising globally. Major players are focusing on global expansion plans by strengthening their distribution networks worldwide and offering innovative aesthetic injectable products.
Market Drivers
Growing demand for non-surgical aesthetic procedures owing to lesser pain, faster recovery time and visible effects is a key driver for this market. Increasing visibility of beauty standards on social media and rising focus on appearance is also driving the market growth. Availability of several dermal filler products at varying price points suitable for all consumer segments boosts the market.
Market Restrains
High costs of certain premium aesthetic injectable products may restrain mass consumption. Lack of knowledgeable practitioners and uneven regulatory frameworks in some regions pose challenges. Side effects and allergies associated with certain injectable fillers act as a restrain. Lack of reimbursements for aesthetic procedures in many countries is another factor limiting market growth.
Segment Analysis
The global aesthetic injectables market is segmented on the basis of product, application and end-user. By product, the dermal fillers segment dominates the market. Dermal fillers are substances used to fill wrinkles, facial lines and folds, augment lips and soft tissue contours. Hyaluronic acid based dermal fillers are widely used due to their ability to effectively fill the skin and reduce the appearance of wrinkles for extended periods with minimal side effects. By application, the facial line correction segment governs over other segments. Facial lines are among the primary signs of aging caused due to muscle contractions and sun exposure. Aesthetic injectables play a major role in effectively treating dynamic wrinkles and fine lines on the face.
Global Analysis
Geographically, North America leads the global aesthetic injectables market, supported by rising demand for anti-aging procedures and greater awareness about aesthetics via social media influencers and celebrities. The large presence of key players and availability of advanced aesthetic treatment options also contribute to North America's dominance in the market.
Meanwhile, Asia Pacific displays the fastest growth, driven by growing medical tourism industry and rapidly increasing middle-class population with higher discretionary spending on aesthetics. Japan, China, South Korea and India offer immense growth opportunities as access to aesthetic procedures becomes widespread. In Europe, countries like Germany, Italy, France and UK revenue streams on account of their strong economies and willingness to spend on aesthetic enhancement procedures.
Get more insights on Aesthetic Injectables Market
Comments
0 comment